nodes	percent_of_prediction	percent_of_DWPC	metapath
Flumazenil—Hiccups—Doxorubicin—kidney cancer	0.00186	0.00186	CcSEcCtD
Flumazenil—Fatigue—Erlotinib—kidney cancer	0.00186	0.00186	CcSEcCtD
Flumazenil—Feeling abnormal—Vinblastine—kidney cancer	0.00185	0.00185	CcSEcCtD
Flumazenil—Injection site reaction—Doxorubicin—kidney cancer	0.00185	0.00185	CcSEcCtD
Flumazenil—Pain—Erlotinib—kidney cancer	0.00184	0.00184	CcSEcCtD
Flumazenil—Feeling abnormal—Everolimus—kidney cancer	0.00184	0.00184	CcSEcCtD
Flumazenil—Erythema—Gemcitabine—kidney cancer	0.00183	0.00183	CcSEcCtD
Flumazenil—Discomfort—Dactinomycin—kidney cancer	0.00182	0.00182	CcSEcCtD
Flumazenil—Salivary hypersecretion—Doxorubicin—kidney cancer	0.0018	0.0018	CcSEcCtD
Flumazenil—Vomiting—Pazopanib—kidney cancer	0.0018	0.0018	CcSEcCtD
Flumazenil—Bradycardia—Paclitaxel—kidney cancer	0.00179	0.00179	CcSEcCtD
Flumazenil—Rash—Pazopanib—kidney cancer	0.00178	0.00178	CcSEcCtD
Flumazenil—Nausea—Temsirolimus—kidney cancer	0.00178	0.00178	CcSEcCtD
Flumazenil—Dermatitis—Pazopanib—kidney cancer	0.00178	0.00178	CcSEcCtD
Flumazenil—Agitation—Vincristine—kidney cancer	0.00178	0.00178	CcSEcCtD
Flumazenil—Headache—Pazopanib—kidney cancer	0.00177	0.00177	CcSEcCtD
Flumazenil—Sweating increased—Capecitabine—kidney cancer	0.00176	0.00176	CcSEcCtD
Flumazenil—Hypoaesthesia—Paclitaxel—kidney cancer	0.00175	0.00175	CcSEcCtD
Flumazenil—Vertigo—Vincristine—kidney cancer	0.00174	0.00174	CcSEcCtD
Flumazenil—Dyspnoea—Sorafenib—kidney cancer	0.00173	0.00173	CcSEcCtD
Flumazenil—Ill-defined disorder—Gemcitabine—kidney cancer	0.0017	0.0017	CcSEcCtD
Flumazenil—Visual impairment—Paclitaxel—kidney cancer	0.0017	0.0017	CcSEcCtD
Flumazenil—Insomnia—Sunitinib—kidney cancer	0.00169	0.00169	CcSEcCtD
Flumazenil—Nausea—Pazopanib—kidney cancer	0.00168	0.00168	CcSEcCtD
Flumazenil—Paraesthesia—Sunitinib—kidney cancer	0.00167	0.00167	CcSEcCtD
Flumazenil—Fatigue—Sorafenib—kidney cancer	0.00167	0.00167	CcSEcCtD
Flumazenil—Hypertension—Vincristine—kidney cancer	0.00167	0.00167	CcSEcCtD
Flumazenil—Dyspnoea—Sunitinib—kidney cancer	0.00166	0.00166	CcSEcCtD
Flumazenil—Pain—Sorafenib—kidney cancer	0.00166	0.00166	CcSEcCtD
Flumazenil—Malaise—Gemcitabine—kidney cancer	0.00165	0.00165	CcSEcCtD
Flumazenil—Hypersensitivity—Vinblastine—kidney cancer	0.00165	0.00165	CcSEcCtD
Flumazenil—Hypersensitivity—Everolimus—kidney cancer	0.00164	0.00164	CcSEcCtD
Flumazenil—Tinnitus—Paclitaxel—kidney cancer	0.00164	0.00164	CcSEcCtD
Flumazenil—Flushing—Paclitaxel—kidney cancer	0.00164	0.00164	CcSEcCtD
Flumazenil—Abnormal vision—Doxorubicin—kidney cancer	0.00162	0.00162	CcSEcCtD
Flumazenil—Asthenia—Vinblastine—kidney cancer	0.00161	0.00161	CcSEcCtD
Flumazenil—Fatigue—Sunitinib—kidney cancer	0.00161	0.00161	CcSEcCtD
Flumazenil—Asthenia—Everolimus—kidney cancer	0.0016	0.0016	CcSEcCtD
Flumazenil—Cough—Gemcitabine—kidney cancer	0.0016	0.0016	CcSEcCtD
Flumazenil—Pain—Sunitinib—kidney cancer	0.00159	0.00159	CcSEcCtD
Flumazenil—Hypertension—Gemcitabine—kidney cancer	0.00158	0.00158	CcSEcCtD
Flumazenil—Chills—Paclitaxel—kidney cancer	0.00158	0.00158	CcSEcCtD
Flumazenil—Pruritus—Everolimus—kidney cancer	0.00158	0.00158	CcSEcCtD
Flumazenil—Arrhythmia—Paclitaxel—kidney cancer	0.00157	0.00157	CcSEcCtD
Flumazenil—Chest pain—Gemcitabine—kidney cancer	0.00156	0.00156	CcSEcCtD
Flumazenil—Thrombophlebitis—Doxorubicin—kidney cancer	0.00156	0.00156	CcSEcCtD
Flumazenil—Asthenia—Erlotinib—kidney cancer	0.00154	0.00154	CcSEcCtD
Flumazenil—Discomfort—Gemcitabine—kidney cancer	0.00154	0.00154	CcSEcCtD
Flumazenil—Urticaria—Sorafenib—kidney cancer	0.00154	0.00154	CcSEcCtD
Flumazenil—Erythema—Paclitaxel—kidney cancer	0.00153	0.00153	CcSEcCtD
Flumazenil—Hyperhidrosis—Vincristine—kidney cancer	0.00152	0.00152	CcSEcCtD
Flumazenil—Pruritus—Erlotinib—kidney cancer	0.00152	0.00152	CcSEcCtD
Flumazenil—Fatigue—Dactinomycin—kidney cancer	0.00152	0.00152	CcSEcCtD
Flumazenil—Pain—Dactinomycin—kidney cancer	0.00151	0.00151	CcSEcCtD
Flumazenil—Tension—Paclitaxel—kidney cancer	0.00151	0.00151	CcSEcCtD
Flumazenil—Nervousness—Paclitaxel—kidney cancer	0.00149	0.00149	CcSEcCtD
Flumazenil—Dizziness—Vinblastine—kidney cancer	0.00148	0.00148	CcSEcCtD
Flumazenil—Dizziness—Everolimus—kidney cancer	0.00148	0.00148	CcSEcCtD
Flumazenil—Hypotension—Vincristine—kidney cancer	0.00147	0.00147	CcSEcCtD
Flumazenil—Bradycardia—Capecitabine—kidney cancer	0.00147	0.00147	CcSEcCtD
Flumazenil—Feeling abnormal—Dactinomycin—kidney cancer	0.00145	0.00145	CcSEcCtD
Flumazenil—Vision blurred—Paclitaxel—kidney cancer	0.00145	0.00145	CcSEcCtD
Flumazenil—Hyperhidrosis—Gemcitabine—kidney cancer	0.00145	0.00145	CcSEcCtD
Flumazenil—Hot flush—Doxorubicin—kidney cancer	0.00144	0.00144	CcSEcCtD
Flumazenil—Hypoaesthesia—Capecitabine—kidney cancer	0.00144	0.00144	CcSEcCtD
Flumazenil—Tremor—Paclitaxel—kidney cancer	0.00144	0.00144	CcSEcCtD
Flumazenil—Menopausal symptoms—Doxorubicin—kidney cancer	0.00143	0.00143	CcSEcCtD
Flumazenil—Hypersensitivity—Sorafenib—kidney cancer	0.00143	0.00143	CcSEcCtD
Flumazenil—Insomnia—Vincristine—kidney cancer	0.00143	0.00143	CcSEcCtD
Flumazenil—Vomiting—Vinblastine—kidney cancer	0.00142	0.00142	CcSEcCtD
Flumazenil—Dizziness—Erlotinib—kidney cancer	0.00142	0.00142	CcSEcCtD
Flumazenil—Ill-defined disorder—Paclitaxel—kidney cancer	0.00142	0.00142	CcSEcCtD
Flumazenil—Vomiting—Everolimus—kidney cancer	0.00142	0.00142	CcSEcCtD
Flumazenil—Paraesthesia—Vincristine—kidney cancer	0.00142	0.00142	CcSEcCtD
Flumazenil—Agitation—Paclitaxel—kidney cancer	0.00141	0.00141	CcSEcCtD
Flumazenil—Rash—Everolimus—kidney cancer	0.00141	0.00141	CcSEcCtD
Flumazenil—Dermatitis—Everolimus—kidney cancer	0.00141	0.00141	CcSEcCtD
Flumazenil—Headache—Vinblastine—kidney cancer	0.0014	0.0014	CcSEcCtD
Flumazenil—Headache—Everolimus—kidney cancer	0.0014	0.0014	CcSEcCtD
Flumazenil—Hypotension—Gemcitabine—kidney cancer	0.0014	0.0014	CcSEcCtD
Flumazenil—Visual impairment—Capecitabine—kidney cancer	0.00139	0.00139	CcSEcCtD
Flumazenil—Asthenia—Sorafenib—kidney cancer	0.00139	0.00139	CcSEcCtD
Flumazenil—Malaise—Paclitaxel—kidney cancer	0.00138	0.00138	CcSEcCtD
Flumazenil—Vertigo—Paclitaxel—kidney cancer	0.00138	0.00138	CcSEcCtD
Flumazenil—Hypersensitivity—Sunitinib—kidney cancer	0.00137	0.00137	CcSEcCtD
Flumazenil—Pruritus—Sorafenib—kidney cancer	0.00137	0.00137	CcSEcCtD
Flumazenil—Vomiting—Erlotinib—kidney cancer	0.00137	0.00137	CcSEcCtD
Flumazenil—Fatigue—Vincristine—kidney cancer	0.00136	0.00136	CcSEcCtD
Flumazenil—Rash—Erlotinib—kidney cancer	0.00136	0.00136	CcSEcCtD
Flumazenil—Dermatitis—Erlotinib—kidney cancer	0.00136	0.00136	CcSEcCtD
Flumazenil—Palpitations—Paclitaxel—kidney cancer	0.00136	0.00136	CcSEcCtD
Flumazenil—Insomnia—Gemcitabine—kidney cancer	0.00135	0.00135	CcSEcCtD
Flumazenil—Headache—Erlotinib—kidney cancer	0.00135	0.00135	CcSEcCtD
Flumazenil—Tinnitus—Capecitabine—kidney cancer	0.00135	0.00135	CcSEcCtD
Flumazenil—Pain—Vincristine—kidney cancer	0.00135	0.00135	CcSEcCtD
Flumazenil—Diplopia—Doxorubicin—kidney cancer	0.00135	0.00135	CcSEcCtD
Flumazenil—Paraesthesia—Gemcitabine—kidney cancer	0.00134	0.00134	CcSEcCtD
Flumazenil—Flushing—Capecitabine—kidney cancer	0.00134	0.00134	CcSEcCtD
Flumazenil—Cough—Paclitaxel—kidney cancer	0.00134	0.00134	CcSEcCtD
Flumazenil—Asthenia—Sunitinib—kidney cancer	0.00134	0.00134	CcSEcCtD
Flumazenil—Dyspnoea—Gemcitabine—kidney cancer	0.00133	0.00133	CcSEcCtD
Flumazenil—Nausea—Vinblastine—kidney cancer	0.00133	0.00133	CcSEcCtD
Flumazenil—Somnolence—Gemcitabine—kidney cancer	0.00133	0.00133	CcSEcCtD
Flumazenil—Affect lability—Doxorubicin—kidney cancer	0.00133	0.00133	CcSEcCtD
Flumazenil—Nausea—Everolimus—kidney cancer	0.00133	0.00133	CcSEcCtD
Flumazenil—Hypertension—Paclitaxel—kidney cancer	0.00132	0.00132	CcSEcCtD
Flumazenil—Pruritus—Sunitinib—kidney cancer	0.00132	0.00132	CcSEcCtD
Flumazenil—Chest pain—Paclitaxel—kidney cancer	0.00131	0.00131	CcSEcCtD
Flumazenil—Anxiety—Paclitaxel—kidney cancer	0.0013	0.0013	CcSEcCtD
Flumazenil—Hypersensitivity—Dactinomycin—kidney cancer	0.0013	0.0013	CcSEcCtD
Flumazenil—Chills—Capecitabine—kidney cancer	0.0013	0.0013	CcSEcCtD
Flumazenil—Arrhythmia—Capecitabine—kidney cancer	0.00129	0.00129	CcSEcCtD
Flumazenil—Discomfort—Paclitaxel—kidney cancer	0.00129	0.00129	CcSEcCtD
Flumazenil—Fatigue—Gemcitabine—kidney cancer	0.00129	0.00129	CcSEcCtD
Flumazenil—Dizziness—Sorafenib—kidney cancer	0.00128	0.00128	CcSEcCtD
Flumazenil—Pain—Gemcitabine—kidney cancer	0.00128	0.00128	CcSEcCtD
Flumazenil—Nausea—Erlotinib—kidney cancer	0.00128	0.00128	CcSEcCtD
Flumazenil—Dry mouth—Paclitaxel—kidney cancer	0.00128	0.00128	CcSEcCtD
Flumazenil—Mood swings—Doxorubicin—kidney cancer	0.00128	0.00128	CcSEcCtD
Flumazenil—Ataxia—Doxorubicin—kidney cancer	0.00127	0.00127	CcSEcCtD
Flumazenil—Asthenia—Dactinomycin—kidney cancer	0.00127	0.00127	CcSEcCtD
Flumazenil—Confusional state—Paclitaxel—kidney cancer	0.00126	0.00126	CcSEcCtD
Flumazenil—Erythema—Capecitabine—kidney cancer	0.00126	0.00126	CcSEcCtD
Flumazenil—Dizziness—Sunitinib—kidney cancer	0.00123	0.00123	CcSEcCtD
Flumazenil—Feeling abnormal—Gemcitabine—kidney cancer	0.00123	0.00123	CcSEcCtD
Flumazenil—Vomiting—Sorafenib—kidney cancer	0.00123	0.00123	CcSEcCtD
Flumazenil—Tachycardia—Paclitaxel—kidney cancer	0.00122	0.00122	CcSEcCtD
Flumazenil—Rash—Sorafenib—kidney cancer	0.00122	0.00122	CcSEcCtD
Flumazenil—Dermatitis—Sorafenib—kidney cancer	0.00122	0.00122	CcSEcCtD
Flumazenil—Headache—Sorafenib—kidney cancer	0.00121	0.00121	CcSEcCtD
Flumazenil—Hyperhidrosis—Paclitaxel—kidney cancer	0.00121	0.00121	CcSEcCtD
Flumazenil—Vision blurred—Capecitabine—kidney cancer	0.00119	0.00119	CcSEcCtD
Flumazenil—Vomiting—Sunitinib—kidney cancer	0.00119	0.00119	CcSEcCtD
Flumazenil—Tremor—Capecitabine—kidney cancer	0.00118	0.00118	CcSEcCtD
Flumazenil—Rash—Sunitinib—kidney cancer	0.00118	0.00118	CcSEcCtD
Flumazenil—Dermatitis—Sunitinib—kidney cancer	0.00117	0.00117	CcSEcCtD
Flumazenil—Hypotension—Paclitaxel—kidney cancer	0.00117	0.00117	CcSEcCtD
Flumazenil—Ill-defined disorder—Capecitabine—kidney cancer	0.00117	0.00117	CcSEcCtD
Flumazenil—Headache—Sunitinib—kidney cancer	0.00117	0.00117	CcSEcCtD
Flumazenil—Hypersensitivity—Vincristine—kidney cancer	0.00116	0.00116	CcSEcCtD
Flumazenil—Nausea—Sorafenib—kidney cancer	0.00115	0.00115	CcSEcCtD
Flumazenil—Malaise—Capecitabine—kidney cancer	0.00114	0.00114	CcSEcCtD
Flumazenil—Insomnia—Paclitaxel—kidney cancer	0.00113	0.00113	CcSEcCtD
Flumazenil—Vertigo—Capecitabine—kidney cancer	0.00113	0.00113	CcSEcCtD
Flumazenil—Asthenia—Vincristine—kidney cancer	0.00113	0.00113	CcSEcCtD
Flumazenil—Paraesthesia—Paclitaxel—kidney cancer	0.00112	0.00112	CcSEcCtD
Flumazenil—Vomiting—Dactinomycin—kidney cancer	0.00112	0.00112	CcSEcCtD
Flumazenil—Dyspnoea—Paclitaxel—kidney cancer	0.00112	0.00112	CcSEcCtD
Flumazenil—Somnolence—Paclitaxel—kidney cancer	0.00111	0.00111	CcSEcCtD
Flumazenil—Palpitations—Capecitabine—kidney cancer	0.00111	0.00111	CcSEcCtD
Flumazenil—Rash—Dactinomycin—kidney cancer	0.00111	0.00111	CcSEcCtD
Flumazenil—Nausea—Sunitinib—kidney cancer	0.00111	0.00111	CcSEcCtD
Flumazenil—Cough—Capecitabine—kidney cancer	0.0011	0.0011	CcSEcCtD
Flumazenil—Hypertension—Capecitabine—kidney cancer	0.00109	0.00109	CcSEcCtD
Flumazenil—Fatigue—Paclitaxel—kidney cancer	0.00108	0.00108	CcSEcCtD
Flumazenil—Asthenia—Gemcitabine—kidney cancer	0.00107	0.00107	CcSEcCtD
Flumazenil—Chest pain—Capecitabine—kidney cancer	0.00107	0.00107	CcSEcCtD
Flumazenil—Pain—Paclitaxel—kidney cancer	0.00107	0.00107	CcSEcCtD
Flumazenil—Anxiety—Capecitabine—kidney cancer	0.00107	0.00107	CcSEcCtD
Flumazenil—Discomfort—Capecitabine—kidney cancer	0.00106	0.00106	CcSEcCtD
Flumazenil—Pruritus—Gemcitabine—kidney cancer	0.00106	0.00106	CcSEcCtD
Flumazenil—Dry mouth—Capecitabine—kidney cancer	0.00105	0.00105	CcSEcCtD
Flumazenil—Nausea—Dactinomycin—kidney cancer	0.00105	0.00105	CcSEcCtD
Flumazenil—Dizziness—Vincristine—kidney cancer	0.00104	0.00104	CcSEcCtD
Flumazenil—Drowsiness—Doxorubicin—kidney cancer	0.00104	0.00104	CcSEcCtD
Flumazenil—Confusional state—Capecitabine—kidney cancer	0.00104	0.00104	CcSEcCtD
Flumazenil—Feeling abnormal—Paclitaxel—kidney cancer	0.00103	0.00103	CcSEcCtD
Flumazenil—Tachycardia—Capecitabine—kidney cancer	0.001	0.001	CcSEcCtD
Flumazenil—Vomiting—Vincristine—kidney cancer	0.001	0.001	CcSEcCtD
Flumazenil—Sweating—Doxorubicin—kidney cancer	0.000996	0.000996	CcSEcCtD
Flumazenil—Urticaria—Paclitaxel—kidney cancer	0.000995	0.000995	CcSEcCtD
Flumazenil—Rash—Vincristine—kidney cancer	0.000994	0.000994	CcSEcCtD
Flumazenil—Hyperhidrosis—Capecitabine—kidney cancer	0.000993	0.000993	CcSEcCtD
Flumazenil—Dermatitis—Vincristine—kidney cancer	0.000993	0.000993	CcSEcCtD
Flumazenil—Headache—Vincristine—kidney cancer	0.000988	0.000988	CcSEcCtD
Flumazenil—Hypotension—Capecitabine—kidney cancer	0.00096	0.00096	CcSEcCtD
Flumazenil—Vomiting—Gemcitabine—kidney cancer	0.000951	0.000951	CcSEcCtD
Flumazenil—Bradycardia—Doxorubicin—kidney cancer	0.000949	0.000949	CcSEcCtD
Flumazenil—Rash—Gemcitabine—kidney cancer	0.000943	0.000943	CcSEcCtD
Flumazenil—Dermatitis—Gemcitabine—kidney cancer	0.000942	0.000942	CcSEcCtD
Flumazenil—Headache—Gemcitabine—kidney cancer	0.000937	0.000937	CcSEcCtD
Flumazenil—Nausea—Vincristine—kidney cancer	0.000936	0.000936	CcSEcCtD
Flumazenil—Insomnia—Capecitabine—kidney cancer	0.000929	0.000929	CcSEcCtD
Flumazenil—Hypoaesthesia—Doxorubicin—kidney cancer	0.000928	0.000928	CcSEcCtD
Flumazenil—Paraesthesia—Capecitabine—kidney cancer	0.000923	0.000923	CcSEcCtD
Flumazenil—Hypersensitivity—Paclitaxel—kidney cancer	0.000923	0.000923	CcSEcCtD
Flumazenil—Dyspnoea—Capecitabine—kidney cancer	0.000916	0.000916	CcSEcCtD
Flumazenil—Visual impairment—Doxorubicin—kidney cancer	0.000899	0.000899	CcSEcCtD
Flumazenil—Asthenia—Paclitaxel—kidney cancer	0.000898	0.000898	CcSEcCtD
Flumazenil—Nausea—Gemcitabine—kidney cancer	0.000888	0.000888	CcSEcCtD
Flumazenil—Fatigue—Capecitabine—kidney cancer	0.000886	0.000886	CcSEcCtD
Flumazenil—Pruritus—Paclitaxel—kidney cancer	0.000886	0.000886	CcSEcCtD
Flumazenil—Pain—Capecitabine—kidney cancer	0.000879	0.000879	CcSEcCtD
Flumazenil—Tinnitus—Doxorubicin—kidney cancer	0.000869	0.000869	CcSEcCtD
Flumazenil—Flushing—Doxorubicin—kidney cancer	0.000865	0.000865	CcSEcCtD
Flumazenil—Feeling abnormal—Capecitabine—kidney cancer	0.000847	0.000847	CcSEcCtD
Flumazenil—Chills—Doxorubicin—kidney cancer	0.000837	0.000837	CcSEcCtD
Flumazenil—Arrhythmia—Doxorubicin—kidney cancer	0.000833	0.000833	CcSEcCtD
Flumazenil—Dizziness—Paclitaxel—kidney cancer	0.000828	0.000828	CcSEcCtD
Flumazenil—Urticaria—Capecitabine—kidney cancer	0.000816	0.000816	CcSEcCtD
Flumazenil—Erythema—Doxorubicin—kidney cancer	0.000812	0.000812	CcSEcCtD
Flumazenil—Tension—Doxorubicin—kidney cancer	0.000796	0.000796	CcSEcCtD
Flumazenil—Vomiting—Paclitaxel—kidney cancer	0.000796	0.000796	CcSEcCtD
Flumazenil—Rash—Paclitaxel—kidney cancer	0.00079	0.00079	CcSEcCtD
Flumazenil—Dermatitis—Paclitaxel—kidney cancer	0.000789	0.000789	CcSEcCtD
Flumazenil—Nervousness—Doxorubicin—kidney cancer	0.000788	0.000788	CcSEcCtD
Flumazenil—Headache—Paclitaxel—kidney cancer	0.000784	0.000784	CcSEcCtD
Flumazenil—Vision blurred—Doxorubicin—kidney cancer	0.000765	0.000765	CcSEcCtD
Flumazenil—Hypersensitivity—Capecitabine—kidney cancer	0.000757	0.000757	CcSEcCtD
Flumazenil—Ill-defined disorder—Doxorubicin—kidney cancer	0.000753	0.000753	CcSEcCtD
Flumazenil—Agitation—Doxorubicin—kidney cancer	0.000746	0.000746	CcSEcCtD
Flumazenil—Nausea—Paclitaxel—kidney cancer	0.000744	0.000744	CcSEcCtD
Flumazenil—Asthenia—Capecitabine—kidney cancer	0.000737	0.000737	CcSEcCtD
Flumazenil—Malaise—Doxorubicin—kidney cancer	0.000732	0.000732	CcSEcCtD
Flumazenil—Vertigo—Doxorubicin—kidney cancer	0.000729	0.000729	CcSEcCtD
Flumazenil—Pruritus—Capecitabine—kidney cancer	0.000727	0.000727	CcSEcCtD
Flumazenil—Palpitations—Doxorubicin—kidney cancer	0.000717	0.000717	CcSEcCtD
Flumazenil—Cough—Doxorubicin—kidney cancer	0.000708	0.000708	CcSEcCtD
Flumazenil—Hypertension—Doxorubicin—kidney cancer	0.000701	0.000701	CcSEcCtD
Flumazenil—Chest pain—Doxorubicin—kidney cancer	0.000691	0.000691	CcSEcCtD
Flumazenil—Anxiety—Doxorubicin—kidney cancer	0.000689	0.000689	CcSEcCtD
Flumazenil—Discomfort—Doxorubicin—kidney cancer	0.000683	0.000683	CcSEcCtD
Flumazenil—Dizziness—Capecitabine—kidney cancer	0.00068	0.00068	CcSEcCtD
Flumazenil—Dry mouth—Doxorubicin—kidney cancer	0.000676	0.000676	CcSEcCtD
Flumazenil—Confusional state—Doxorubicin—kidney cancer	0.000668	0.000668	CcSEcCtD
Flumazenil—Vomiting—Capecitabine—kidney cancer	0.000653	0.000653	CcSEcCtD
Flumazenil—Rash—Capecitabine—kidney cancer	0.000648	0.000648	CcSEcCtD
Flumazenil—Dermatitis—Capecitabine—kidney cancer	0.000647	0.000647	CcSEcCtD
Flumazenil—Tachycardia—Doxorubicin—kidney cancer	0.000646	0.000646	CcSEcCtD
Flumazenil—Headache—Capecitabine—kidney cancer	0.000644	0.000644	CcSEcCtD
Flumazenil—Hyperhidrosis—Doxorubicin—kidney cancer	0.00064	0.00064	CcSEcCtD
Flumazenil—Hypotension—Doxorubicin—kidney cancer	0.000619	0.000619	CcSEcCtD
Flumazenil—Nausea—Capecitabine—kidney cancer	0.00061	0.00061	CcSEcCtD
Flumazenil—Insomnia—Doxorubicin—kidney cancer	0.000599	0.000599	CcSEcCtD
Flumazenil—Paraesthesia—Doxorubicin—kidney cancer	0.000595	0.000595	CcSEcCtD
Flumazenil—Dyspnoea—Doxorubicin—kidney cancer	0.000591	0.000591	CcSEcCtD
Flumazenil—Somnolence—Doxorubicin—kidney cancer	0.000589	0.000589	CcSEcCtD
Flumazenil—Fatigue—Doxorubicin—kidney cancer	0.000571	0.000571	CcSEcCtD
Flumazenil—Pain—Doxorubicin—kidney cancer	0.000566	0.000566	CcSEcCtD
Flumazenil—Feeling abnormal—Doxorubicin—kidney cancer	0.000546	0.000546	CcSEcCtD
Flumazenil—Urticaria—Doxorubicin—kidney cancer	0.000526	0.000526	CcSEcCtD
Flumazenil—Hypersensitivity—Doxorubicin—kidney cancer	0.000488	0.000488	CcSEcCtD
Flumazenil—Asthenia—Doxorubicin—kidney cancer	0.000475	0.000475	CcSEcCtD
Flumazenil—Pruritus—Doxorubicin—kidney cancer	0.000469	0.000469	CcSEcCtD
Flumazenil—Dizziness—Doxorubicin—kidney cancer	0.000438	0.000438	CcSEcCtD
Flumazenil—Vomiting—Doxorubicin—kidney cancer	0.000421	0.000421	CcSEcCtD
Flumazenil—Rash—Doxorubicin—kidney cancer	0.000418	0.000418	CcSEcCtD
Flumazenil—Dermatitis—Doxorubicin—kidney cancer	0.000417	0.000417	CcSEcCtD
Flumazenil—Headache—Doxorubicin—kidney cancer	0.000415	0.000415	CcSEcCtD
Flumazenil—Nausea—Doxorubicin—kidney cancer	0.000393	0.000393	CcSEcCtD
